Medicine Quality | Infectious Diseases Data Observatory

i

Medicine Quality

By sharing global expertise and collating information, IDDO strengthens knowledge of the scale of the problem of poor quality medicines and the most affected areas, and raises vital awareness among key stakeholders.

Impact of poor quality medicines

Medicines are of vital importance in health systems, and access to quality-assured medicines is part of the basic right to health. Nevertheless, poor quality medical products, including medicines, vaccines and diagnostic devices, are widespread due to poor manufacture (substandard medicines) or deliberate falsiﬁcation. Poor quality medicines jeopardise national, regional and global attempts to improve access to effective health care because they lead to avoidable morbidity and mortality, waste ﬁnancial resources, and contribute to drug resistance.

Our work

Publications

Medicine Quality & Public Health Conference 2018

The first-ever dedicated academic conference on Medicine Quality & Public Health took place in Oxford, United Kingdom, from 23 – 28 September 2018. It brought together people from a diversity of sectors working in this field, such as public health, national regulatory authorities, pharmacy, biomedical, chemistry, law, ethics, cultural and social sciences, the pharmaceutical industry, international organisations, NGOs, national procurement centres, and internet and pharmaceutical forensics. The Oxford statement was released shortly after the conference. A fuller statement will be published in the new year.

About the conference

Read the Oxford Statement